We use cookies for a better user experience. Read our Privacy Policy

I Agree

Preterm Birth and PROM Testing Market Insights, 2018-2026

Preterm Birth and PROM Testing Market (Test Type - Preterm Birth Tests, PROM Tests; End user - Hospitals, Diagnostic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Preterm Birth and PROM Testing Market: Summary

One of the major and critical health issues faced by females across the world is preterm birth, caused chiefly by a medical condition known as ‘premature rupture of membranes’ or PROM. Increase in the preterm birth instances owing to the rise in the standard age of female population while pregnant is one of the most prominent driving factors supporting the rising sales in global preterm birth and PROM testing market. Furthermore, rise in various health issues such as diabetes as well as high blood pressure that can create complications in pregnancy is also one of the pivotal drivers for the expansion of the global preterm birth and PROM testing market.

Types of tests provided by the manufacturers and players operational within the global preterm birth and PROM testing market include PROM tests (including Ferning test, ultrasound, biomarker tests, nitrazine tests, pooling, and fetal fibronectin tests, among others) and preterm birth tests (including ultrasound, biomarkers, pelvic exam, and uterine monitoring). Among these, PROM testing segment dominated the global preterm birth and PROM testing market in recent past, owing to several factors, such as rising incidence of preterm birth, increasing number of specialty clinics, facilitate of easy detection of preterm birth by using PROM tests. However, in terms of revenue, the preterm birth tests segment is likely to dominate the global preterm birth and PROM testing market in coming years.

Major end user for the solutions and products in the global preterm birth and PROM testing market are diagnostic laboratories and hospitals, among others. Based on end user, the diagnostic laboratories segment led the global preterm birth and PROM testing market in recent years, owing to the rising awareness pertaining to specialty treatments as well as the increase in demand for preterm diagnostic procedures.

preterm-birth-prom-testing-market.jpg

North America Leads the Preterm Birth and PROM Testing Market

Major geographical regions and leading nations functional within the global preterm birth and PROM testing market include Europe (including the United Kingdom, France, Germany, Italy, Spain, and rest of the Europe), North America (including Canada and the United States), Asia Pacific (including China, Australia, India, Japan, New Zealand, and rest of the Asia Pacific), Middle East and Africa (including South Africa, the Gulf Cooperation Council countries, Israel, and rest of the Middle East and Africa), and Latin America (including Mexico, Brazil, and rest of the Latin America).

Among these, the North America region is gaining prominence in the global preterm birth and PROM testing market, owing to rising demand for pre-birth testing as well as increase in the rates of preterm births. Furthermore, other significant factors driving the growth in the global preterm birth and PROM testing market in North America include various technological advancements, presence of multiple leading players in the region, and increase in the number of approvals for PROM and preterm testing methods. Moreover, rising focus on early diagnosis of female health problems as well as rising number of government initiatives aimed at bettering maternal heath are driving the development of the global preterm birth and PROM testing market in Europe region in coming years.

Players in Preterm Birth and PROM Testing Market Focused on Technological Advancements

Some of the major incumbent players and manufacturers working in the domain of the global preterm birth and PROM testing market include Hologic, Inc., Biosynex, Clinical Innovations, LLC, The Cooper Companies, Inc., IQ Products, QIAGEN, MediX Biochemica, Abbott Laboratories, Sera Prognostics, Inc., and NX Prenatal, Inc., among others. Players and manufacturers operational within the global preterm birth and PROM testing market are focusing on technological advancements in order to provide enhanced and technologically superior testing and therapeutic products. This trend is anticipated to favor the expansion of the global preterm birth and PROM testing market in coming years.

The global preterm birth and PROM testing market has been segmented as below:

Test Type

  • Preterm Birth Tests
    • Pelvic Exam
    • Ultrasound
    • Uterine Monitoring
    • Biomarkers
  • PROM Tests
    • Nitrazine Test
    • Ferning Test
    • Pooling
    • Ultrasound
    • Fetal Fibronectin Test
    • Biomarker Tests
    • Others

End-user

  • Hospitals
  • Diagnostics Laboratories
  • Others

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Rest of Middle East & Africa
Preterm Birth and PROM Testing Market Insights, 2018-2026

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of preterm birth and PROM testing market?

Preterm birth and PROM testing market to reach US$ 294.2 Mn by 2026

What is the anticipated CAGR of the preterm birth and PROM testing market in the forecast period?

Preterm birth and PROM testing market is anticipated expand at a CAGR of 8.0% from 2018 to 2026

What are the key driving factors for the growth of the preterm birth and PROM testing market?

Preterm birth and PROM testing market is driven by increase in the preterm birth instances owing to the rise in the standard age of female population while pregnant

What are the end-use segments in the preterm birth and PROM testing market?

The end-use segments in global preterm birth and PROM testing market are diagnostic laboratories and hospitals

Who are the key players in the global preterm birth and PROM testing market?

Key players operating in the global preterm and PROM testing market include NX Prenatal, Inc., IQ Products, QIAGEN, Hologic, Inc., The Cooper Companies, Inc., Medix Biochemica, Abbott Laboratories, Clinical Innovations, LLC, Sera Prognostics

1. Preface
   1.1. Market Definition and Scope
   1.2. Market Segmentation
   1.3. Key Research Objectives
   1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Preterm Birth and PROM Testing Market

4. Market Overview
   4.1. Global Preterm Birth and PROM Testing Market Outlook
   4.2. Global Preterm Birth and PROM Testing Market Analysis and Forecasts, 2016–2026
   4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities

5. Key Insights
   5.1. Technological Advancements
   5.2. Expansion and Collaborations
   5.2. Epidemiology of Preterm Birth, by Country

6. Global Preterm Birth and PROM Testing Market Analysis and Forecasts, by Test Type
   6.1. Introduction & Definition
   6.2. Key Findings / Developments
   6.3. Market Value Forecast, by Test Type, 2016–2026
        6.3.1. Preterm Birth Tests
               6.3.1.1. Pelvic Exam
               6.3.1.2. Ultrasound
               6.3.1.3. Uterine Monitoring
               6.3.1.4. Biomarkers
        6.3.2. PROM Tests
               6.3.2.1. Nitrazine Test
               6.3.2.2. Ferning Test
               6.3.2.3. Pooling
               6.3.2.4. Ultrasound
               6.3.2.5. Fetal Fibronectin Test
               6.3.2.6. Biomarker Tests
               6.3.2.5. Others
   6.4. Market Attractiveness, by Test Type

7. Global Preterm Birth and PROM Testing Market Analysis and Forecasts, by End-user
   7.1. Introduction & Definition
   7.2. Key Findings / Developments
   7.3. Market Value Forecast, by End-user, 2016–2026
        7.3.1. Hospitals
        7.3.2. Diagnostic Laboratories
        7.3.3. Others
   7.4. Market Attractiveness, by End-user

8. Global Preterm Birth and PROM Testing Market Analysis and Forecasts, by Region
   8.1. Key Findings
   8.2. Market Value Forecast, by Region
        8.2.1. North America
        8.2.2. Europe
        8.2.3. Asia Pacific
        8.2.4. Latin America
        8.2.5. Middle East & Africa
   8.3. Market Attractiveness, by Country/Region

9. North America Preterm Birth and PROM Testing Market Analysis and Forecast
   9.1. Introduction
        9.1.1. Key Findings
   9.2. Market Value Forecast, by Test Type, 2016–2026
        9.2.1. Preterm Birth Tests
               9.2.1.1. Pelvic Exam
               9.2.1.2. Ultrasound
               9.2.1.3. Uterine Monitoring
               9.2.1.4. Biomarkers
        9.2.2. PROM Tests
               9.2.2.1. Nitrazine Test
               9.2.2.2. Ferning Test
               9.2.2.3. Pooling
               9.2.2.4. Ultrasound
               9.2.2.5. Fetal Fibronectin Test
               9.3.2.6. Biomarker Tests
               9.3.2.5. Others
   9.3. Market Value Forecast, by End-user, 2016–2026
        9.3.1. Hospitals
        9.3.2. Diagnostic Laboratories
        9.3.3. Others
   9.4. Market Value Forecast, by Country, 2016–2026
        9.4.1. U.S.
        9.4.2. Canada
   9.5. Market Attractiveness Analysis
        9.5.1. By Test Type
        9.5.2. By End-user
        9.5.3. By Country

10. Europe Preterm Birth and PROM Testing Market Analysis and Forecast
   10.1. Introduction
        10.1.1. Key Findings
   10.2. Market Value Forecast, by Test Type, 2016–2026
        10.2.1. Preterm Birth Tests
               10.2.1.1. Pelvic Exam
               10.2.1.2. Ultrasound
               10.2.1.3. Uterine Monitoring
               10.2.1.4. Biomarkers
        10.2.2. PROM Tests
               10.2.2.1. Nitrazine Test
               10.2.2.2. Ferning Test
               10.2.2.3. Pooling
               10.2.2.4. Ultrasound
               10.2.2.5. Fetal Fibronectin Test
               10.3.2.6. Biomarker Tests
               10.3.2.5. Others
   10.3. Market Value Forecast, by End-user, 2016–2026
        10.3.1. Hospitals
        10.3.2. Diagnostic Laboratories
        10.3.3. Others
   10.4. Market Value Forecast, by Country/Sub-region, 2016–2026
        10.4.1. Germany
        10.4.2. U.K.
        10.4.3. France
        10.4.4. Spain
        10.4.5. Italy
        10.4.6. Rest of Europe
   10.5. Market Attractiveness Analysis
        10.5.1. By Test Type
        10.5.2. By End-user
        10.5.3. By Country/Sub-region

11. Asia Pacific Preterm Birth and PROM Testing Market Analysis and Forecast
   11.1.Introduction
        11.1.1. Key Findings
   11.2.Market Value Forecast, by Test Type, 2016–2026
        11.2.1. Preterm Birth Tests
               11.2.1.1. Pelvic Exam
               11.2.1.2. Ultrasound
               11.2.1.3. Uterine Monitoring
               11.2.1.4. Biomarkers
        11.2.2. PROM Tests
               11.2.2.1. Nitrazine Test
               11.2.2.2. Ferning Test
               11.2.2.3. Pooling
               11.2.2.4. Ultrasound
               11.2.2.5. Fetal Fibronectin Test
               11.3.2.6. Biomarker Tests
               11.3.2.5. Others
   11.3.Market Value Forecast, by End-user, 2016–2026
        11.3.1. Hospitals
        11.3.2. Diagnostic Laboratories
        11.3.3. Others
   11.4.Market Value Forecast, by Country/Sub-region, 2016–2026
        11.4.1. China
        11.4.2. Japan
        11.4.3. India
        11.4.4. Australia & New Zealand
        11.4.5. Rest of Asia Pacific
   11.5.Market Attractiveness Analysis
        11.5.1. By Test Type
        11.5.2. By End-user
        11.5.3. By Country/Sub-region

12. Latin America Preterm Birth and PROM Testing Market Analysis and Forecast
   12.1.Introduction
        12.1.1. Key Findings
   12.2.Market Value Forecast, by Test Type, 2016–2026
        12.2.1. Preterm Birth Tests
               12.2.1.1. Pelvic Exam
               12.2.1.2. Ultrasound
               12.2.1.3. Uterine Monitoring
               12.2.1.4. Biomarkers
        12.2.2. PROM Tests
               12.2.2.1. Nitrazine Test
               12.2.2.2. Ferning Test
               12.2.2.3. Pooling
               12.2.2.4. Ultrasound
               12.2.2.5. Fetal Fibronectin Test
               12.3.2.6. Biomarker Tests
               12.3.2.5. Others
   12.3.Market Value Forecast, by End-user, 2016–2026
        12.3.1. Hospitals
        12.3.2. Diagnostic Laboratories
        12.3.3. Others
   12.4.Market Value Forecast, by Country/Sub-region, 2016–2026
        12.4.1. Brazil
        12.4.2. Mexico
        12.4.3. Rest of Latin America
   12.5.Market Attractiveness Analysis
        12.5.1. By Test Type
        12.5.2. By End-user
        12.5.3. By Country/Sub-region

13. Middle East & Africa Preterm Birth and PROM Testing Market Analysis and Forecast
   13.1.Introduction
        13.1.1. Key Findings
   13.2.Market Value Forecast, by Test Type, 2016–2026
        13.2.1. Preterm Birth Tests
               13.2.1.1. Pelvic Exam
               13.2.1.2. Ultrasound
               13.2.1.3. Uterine Monitoring
               13.2.1.4. Biomarkers
        13.2.2. PROM Tests
               13.2.2.1. Nitrazine Test
               13.2.2.2. Ferning Test
               13.2.2.3. Pooling
               13.2.2.4. Ultrasound
               13.2.2.5. Fetal Fibronectin Test
               13.3.2.6. Biomarker Tests
               13.3.2.5. Others
   13.3.Market Value Forecast, by End-user, 2016–2026
        13.3.1. Hospitals
        13.3.2. Diagnostic Laboratories
        13.3.3. Others
   13.4.Market Value Forecast, by Country/Sub-region, 2016–2026
        13.4.1. GCC Countries
        13.4.2. South Africa
        13.4.3. Rest of Middle East & Africa
   13.5.Market Attractiveness Analysis
        13.5.1. By Test Type
        13.5.2. By End-user
        13.5.3. By Country/Sub-region

14. Competitive Landscape
   14.1. Global Preterm Birth and PROM Testing Market Analysis, by Top Company Ranking, 2017
   14.2. Company Profiles
        14.2.1. QIAGEN
        14.2.2. Hologic, Inc.
        14.2.3. Medix Biochemica
        14.2.4. Biosynex
        14.2.5. Abbott Laboratories
        14.2.6. Clinical Innovations, LLC.
        14.2.7. Sera Prognostics, Inc.
        14.2.8. Cooper Companies, Inc.
        14.2.9. NX Prenatal, Inc.
        14.2.10. IQ Products

List of Tables

Table 01 Global Preterm Birth and PROM Testing Market Value (US$ Mn) Forecast, by Test Type, 2016–2026
Table 02 Global Preterm Birth and PROM Testing Market Value (US$ Mn) Forecast, by Preterm Birth Tests, 2016–2026
Table 03 Global Preterm Birth and PROM Testing Market Value (US$ Mn) Forecast, by Biomarkers, 2016–2026
Table 04 Global Preterm Birth and PROM Testing Market Value (US$ Mn) Forecast, by PROM Tests, 2016–2026
Table 05 Global Preterm Birth and PROM Testing Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 06 Global Preterm Birth and PROM Testing Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 07 North America Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by Country, 2016–2026
Table 08 North America Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by Test Type, 2016–2026
Table 09 North America Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by Preterm Birth Tests, 2016–2026
Table 10 North America Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by Biomarkers, 2016–2026
Table 11 North America Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by PROM Tests, 2016–2026
Table 12 North America Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by End-user, 2016–2026
Table 13 Europe Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 14 Europe Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by Test Type, 2016–2026
Table 15 Europe Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by Preterm Birth Tests, 2016–2026
Table 16 Europe Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by Biomarkers, 2016–2026
Table 17 Europe Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by PROM Tests, 2016–2026
Table 18 Europe Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by End-user, 2016–2026
Table 19 Asia Pacific Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 20 Asia Pacific Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by Test Type, 2016–2026
Table 21 Asia Pacific Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by Preterm Birth Tests, 2016–2026
Table 22 Asia Pacific Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by Biomarkers, 2016–2026
Table 23 Asia Pacific Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by PROM Tests, 2016–2026
Table 24 Asia Pacific Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by End-user, 2016–2026
Table 25 Latin America Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 26 Latin America Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by Test Type, 2016–2026
Table 27 Latin America Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by Preterm Birth Tests, 2016–2026
Table 28 Latin America Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by Biomarkers, 2016–2026
Table 29 Latin America Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by PROM Tests, 2016–2026
Table 30 Latin America Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by End-user, 2016–2026
Table 31 Middle East & Africa Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 32 Middle East & Africa Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by Test Type, 2016–2026
Table 33 Middle East & Africa Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by Preterm Birth Tests, 2016–2026
Table 34 Middle East & Africa Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by Biomarkers, 2016–2026
Table 35 Middle East & Africa Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by PROM Tests, 2016–2026
Table 36 Middle East & Africa Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast, by End-user, 2016–2026

List of Figures

Figure 01 Global Preterm Birth and PROM Testing Market Value (US$ Mn) Forecast, 2016–2026
Figure 02 Global Preterm Birth and PROM Testing Market Value Share Analysis, by Test Type, 2017 and 2026
Figure 03 Global Preterm Birth and PROM Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Preterm Birth Tests, 2016–2026
Figure 04 Global Preterm Birth and PROM Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%),by PROM Tests 2016–2026
Figure 05 Global Preterm Birth and PROM Testing Market Attractiveness Analysis, by Test Type, 2017
Figure 06 Global Preterm Birth and PROM Testing Market Value Share Analysis, by End-user, 2017 and 2026
Figure 07 Global Preterm Birth and PROM Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2016–2026
Figure 08 Global Preterm Birth and PROM Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2016–2026
Figure 09 Global Preterm Birth and PROM Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 10 Global Preterm Birth and PROM Testing Market Attractiveness Analysis, by End-user
Figure 11 Global Preterm Birth and PROM Testing Market Value Share Analysis, by Region, 2017 and 2026
Figure 12 Global Preterm Birth and PROM Testing Market Attractiveness Analysis, by Region
Figure 13 North America Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 14 North America Preterm Birth and PROM Testing Market Value Share (%), by Country, 2017 and 2026
Figure 15 North America Preterm Birth and PROM Testing Market Attractiveness, by Country, 2018–2026
Figure 16 North America Preterm Birth and PROM Testing Market Value Share (%), by Test Type, 2017 and 2026
Figure 17 North America Preterm Birth and PROM Testing Market Attractiveness, by Test Type, 2018–2026
Figure 18 North America Preterm Birth and PROM Testing Market Value Share (%), by End-user, 2017 and 2026
Figure 19 North America Preterm Birth and PROM Testing Market Attractiveness, by End-user, 2018–2026
Figure 20 Europe Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 21 Europe Preterm Birth and PROM Testing Market Value Share (%), by Country/Sub-region, 2017 and 2026
Figure 22 Europe Preterm Birth and PROM Testing Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 23 Europe Preterm Birth and PROM Testing Market Value Share (%), by Test Type, 2017 and 2026
Figure 24 Europe Preterm Birth and PROM Testing Market Attractiveness, by Test Type, 2018–2026
Figure 25 Europe Preterm Birth and PROM Testing Market Value Share (%), by End-user, 2017 and 2026
Figure 26 Europe Preterm Birth and PROM Testing Market Attractiveness, by End-user, 2018–2026
Figure 27 Asia Pacific Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 28 Asia Pacific Preterm Birth and PROM Testing Market Value Share (%), by Country/Sub-region, 2017 and 2026
Figure 29 Asia Pacific Preterm Birth and PROM Testing Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 30 Asia Pacific Preterm Birth and PROM Testing Market Value Share (%), by Test Type, 2017 and 2026
Figure 31 Asia Pacific Preterm Birth and PROM Testing Market Attractiveness, by Test Type, 2018–2026
Figure 32 Asia Pacific Preterm Birth and PROM Testing Market Value Share (%), by End-user, 2017 and 2026
Figure 33 Asia Pacific Preterm Birth and PROM Testing Market Attractiveness, by End-user, 2018–2026
Figure 34 Latin America Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 35 Latin America Preterm Birth and PROM Testing Market Value Share (%), by Country/Sub-region, 2017 and 2026
Figure 36 Latin America Preterm Birth and PROM Testing Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 37 Latin America Preterm Birth and PROM Testing Market Value Share (%), by Test Type, 2017 and 2026
Figure 38 Latin America Preterm Birth and PROM Testing Market Attractiveness, by Test Type, 2018–2026
Figure 39 Latin America Preterm Birth and PROM Testing Market Value Share (%), by End-user, 2017 and 2026
Figure 40 Latin America Preterm Birth and PROM Testing Market Attractiveness, by End-user, 2018–2026
Figure 41 Middle East & Africa Preterm Birth and PROM Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 42 Middle East & Africa Preterm Birth and PROM Testing Market Value Share (%), by Country/Sub-region, 2017 and 2026
Figure 43 Middle East & Africa Preterm Birth and PROM Testing Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 44 Middle East & Africa Preterm Birth and PROM Testing Market Value Share (%), by Test Type, 2017 and 2026
Figure 45 Middle East & Africa Preterm Birth and PROM Testing Market Attractiveness, by Test Type, 2018–2026
Figure 46 Middle East & Africa Preterm Birth and PROM Testing Market Value Share (%), by End-user, 2017 and 2026
Figure 47 Middle East & Africa Preterm Birth and PROM Testing Market Attractiveness, by End-user, 2018–2026
Figure 48 Global Preterm Birth and PROM Testing Market Analysis, by Top Company Ranking, 2017
Figure 49 QIAGEN Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 50 QIAGEN Breakdown of Net Sales (%), by Region/Country, 2017
Figure 51 QIAGEN Breakdown of Net Sales (%), by Business Segment, 2017
Figure 52 QIAGEN R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 53 Hologic, Inc. Global Preterm Birth and PROM Testing Market Analysis, by Top Company Ranking, 2017
Figure 54 Hologic, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 55 Hologic, Inc. Breakdown of Net Sales (%), by Region/Country, 2017
Figure 56 Hologic, Inc. Breakdown of Net Sales (%), by Business Segment, 2017
Figure 57 Hologic, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 58 Biosynex Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 59 Abbott Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 60 Abbott Breakdown of Net Sales (%), by Region/Country, 2017
Figure 61 Abbott Breakdown of Net Sales (%), by Business Segment, 2017
Figure 62 Abbott R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 63 Cooper Companies, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 64 Cooper Companies, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 65 Cooper Surgical, Inc. Breakdown of Net Sales (%), by Business Segment, 2017

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

307

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved